Radiation mitigation effect of cultured mushroom fungus Hirsutella Sinensis (CorImmune) isolated from a Chinese/Tibetan herbal preparation - Cordyceps Sinensis

International Journal of Radiation Biology

Volumn 84, Issue 2, 2008, Pages 139-149

  Xun, Changqing ^a,b   Shen, Nanying ^a   Li, Bangliang ^a   Zhang, Yonghua ^a   Wang, Frank ^a   Yang, Yingxin ^a   Shi, Xin ^a   Schafermyer, Kim ^a   Brown, Stephen A ^a   Thompson, John S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Chemo radiotherapy; Haematology; Radiation; Radiation mitigation

Indexed keywords

CORDYCEPS SINENSIS EXTRACT; CORIMMUNE; FUNGAL PROTEIN; HERBACEOUS AGENT; HIRSUTELLA SINENSIS EXTRACT; SODIUM CHLORIDE; THYMIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CELL; CELL SURVIVAL; CONTROLLED STUDY; CORDYCEPS SINENSIS; DOSE RESPONSE; DRUG SYNTHESIS; FUNGUS; FUNGUS CULTURE; FUNGUS ISOLATION; HEMATOPOIETIC CELL; HIRSUTELLA SINENSIS; HYPOTHESIS; LETHAL DOSE; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MALE; MOUSE; MUSHROOM; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; SPLEEN CELL; WHOLE BODY RADIATION;

ANIMALS; CORDYCEPS; HEMATOPOIESIS; HYPOCREALES; MICE; MICE, INBRED BALB C; PLANT PREPARATIONS; RADIATION INJURIES; SODIUM CHLORIDE; SPLEEN; SURVIVAL RATE; TIME FACTORS;

ANIMALIA; BASIDIOMYCOTA; CORDYCEPS SINENSIS; FUNGI; MUS;

EID: 38849131953     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000701797070     Document Type: Article

References (33)

1. Bairati I, Meyer F, Jobin E, Gelinas M, Fortin A, Nabid A, Brochet F, Tetu B. 2006. Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients. International Journal of Cancer 119(9):2221-2224.
2. Bunn HF. 2007. New agents that stimulate erythropoiesis. Blood 109(3):866-873.
3. Cersosimo RJ. 2005. Oxaliplatin-associated neuropathy: A review. Annals of Pharmacotherapy 39(1):128-135.
4. Chen SJ, Zhang ZH, An LH, Dong GF, Yong AN. 2000. [The change of free radical in the serum of patients with viral hepatitis and Corbrin (CorImmune) capsule's effect on the free radicals]. Shangdong Medical and Pharmaceutical Journal 40(9):15-19.
5. Coleman CN, Stone H, Moulder JE, Pellmar TC. 2004. Modulation of radiation injury. Science 304:693-694.
6. Dirier A, Akmansu M, Bora H, Gurer M. 2007. The effect of vitamin E on acute skin reaction caused by radiotherapy. Clinical Experimental Dermatology. Clinical Experimental Dermatology 32(5):571-573.
7. Flora SJ. 2007. Role of free radicals and antioxidants in health and disease. Cell Molecule Biology 15;53(1):1-2.
8. Guan J, Wan XS, Zhou Z, Ware J, Donahue JJ, Biaglow JE, Kennedy AR. 2004. Effects of dietary supplements on space radiation-induced oxidative stress in Sprague-Dawley rats. Radiation Research 162(5):572-579.
9. Halliwell B, Gutteridge JM. 1984. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 23(1):1396-1397.
10. Hartmann LC, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA, Levitt R, Suman VJ, Witzig TE, Wieand HS, Miller LL, Moertel CG. 1997. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. New England Journal of Medicine 336(25):1776-1780.
11. Hao JW. 1998. [Corbrin (CorImmune) in treatment of drug-induced leukocytopenia in renal transplant patients. Chinese Journal of New Drugs 7(4):292-298.
12. He Q, Chen JG, Wang YM, Wu YY. 2003. Clinical analysis of the leukocytopenia caused by Mycophenolate mofetil in renal transplants. Chinese Journal of Organ Transplant 24(3):148-151.
13. Jagetia GC, Venkatesh P. 2005. Radioprotection by oral administration of Aegle marmelos Correa in vivo. Journal of Environment Pathology Toxicology Oncology 24:315-332.
14. Ke CK. 2005. Study of Cordycepsis sinensis in China. Beijing China: Chinese Academy of Sciences Publishing Inc.
15. Kolb JH, Mitterm AJ, Clemm CH, Holler G, Ledderose G, Brehm G, Wilmanns W. 1990. Donor leukocyte transfusion for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462-2465.
16. Koukourakis MI. 2002. Amifostine in clinical oncology: Current use and future applications. Anti-cancer Drugs 13(3):181-209.
17. Patchen ML. 1995. Amifostine plus granulocyte colony-stimulating factor therapy enhances recovery from supralethal radiation exposure: Preclinical experience in animal models. European Journal of Cancer 31A:S17-21.
18. Qiang MB, Ding HB, Zhou D. 2001. Clinical report of Corbrin treatment in hepatitis B. Huadong Medicine 2:15-18.
19. Quastler H. 1991. Studies on roentgen death in mice. America Journal of Roentgenology 45:449-456.
20. Sasse AD, Clark LGO, Sasse EC, Clark OAC. 2006. Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis. International Journal of Radiation Oncology Biology Physics 64:784-791.
21. Solomon FC, Marston Q. 1986. The medical implications of nuclear war. Washington DC: National Academic Press.
22. Stickney DR, Dowding C, Authier S, Garsd A, Onizuka-Handa N, Rading C, Frincke JM. 2007. 5-androstenediol improves survival in clinically unsupported rhesus moneys with radiation-induced myelosuppression. International Immunopharmacology 7(4):500-505.
23. Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, Dynan WS, Fike JR, Grdina DJ, Greenberger JS, Hauer-Jensen M, Hill RP, Kolesnick RN, Macvittie TJ, Marks C, McBride WH, Metting N, Pellmar T, Purucker M, Robbins ME, Schiestle RH, Seed TM, Tomaszewski JE, Travis EL, Wallner PE, Wolpert M, Zaharevitz D. 2004. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiation Research. Dec;162(6):711-728.
24. Viresendorp HM. 2003. Aim of conditioning. Experimental Hematology 31:844-854.
25. Vriesendorp HM, van Bekkum DW. 1984. Susceptibility to total body irradiation. In: Broerse JJ, MacVitti T, editors. Response to total body irradiation in different species. Amsterdam: Martinus Nijhoff. pp 43-53.
26. Wang ZH, Cai YL, Lu SJ, Zhang L. 2003. Auxiliary therapeutic effect of Corbrin (CorImmune) capsule for cancer patients accepted radiology. Chinese Journal of Medicine 3;8:681-863.
27. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N. 2004. Strategic national stockpile radiation working group. Annual Internal Medicine 140:1037-1051.
28. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. 1981. Anti-leukemic effect of chronic GVHD in human recipients of allogeneic marrow grafts. New England Journal of Medicine 300:1068-1073.
29. Xun CQ, Thompson JS, Jennings D, Brown SA. 1994. Effect of total body irradiation, busulfan-cyclophosphamide CD or cyclophosphamide on inflammatory cytokine release and development of acute and chronic graft versus host disease in H-2 incompatible transplanted SCID mice. Blood 83:2360-2367.
30. Yang ZH, Ling YS. 1997. Anti-oxidant and free radical effect of Corbrin (CorImmune). Guangdong Journal of Pharmacology 13(1):35-37.
31. Yu HY. 1991. Corbrin (CorImmune) capsule in renal transplantation. Chinese Journal of Urinary Surgery 12(5):328-331.
32. Zhang NZ. 1997. The curative effect of Corbrin (CorImmune) capsule in 58 pulmonary tuberculosis patients on short-term chemotherapy. ShenZhen Journal of Traditional and Western Medicine 7(4):14-17.
33. Zhou DH, Lauderback CM, Yu T, Brown SA, Butterfield DA, Thompson JS. 1999. A high dose of ionization radiation induces tissue-specific activation of nuclear factor-kappa B in vivo. Radiation Research 151(6):703-709.